Carlos Vergés, José Salgado-Borges* and Francesc March de Ribot
Intensity Pulsed Light (IPL) is one of the new treatments for patients with Dry Eye (DED) and Meibomian Gland Dysfunction (MGD), showing a high level of efficacy and safety but still we don’t know well the exact mechanisms of action and the criteria on how to apply this technology and the type of patient in whom IPL treatment would be indicated.
